Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Cantor Fitzgerald
Argus Health
Boehringer Ingelheim
Baxter
Teva
UBS
Covington

Generated: May 24, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: raloxifene hydrochloride

« Back to Dashboard

raloxifene hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company N 0002-4184-02
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company N 0002-4184-07
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company N 0002-4184-30
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS N 0179-0151-70
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
US Army
Farmers Insurance
Federal Trade Commission
McKinsey
Boehringer Ingelheim
UBS
Baxter